Name: Cleo Diagnostics (COV) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

COV

Pharmaceuticals, Biotechnology & Life Sciences

Cleo Diagnostics

Short interest: 0.00%; 0.00 pp 30d; as of 24 Aug 2026
Reported shorts: 6.3K
Shares on issue: 137.112M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Cleo Diagnostics

Cleo Diagnostics is a medical diagnostics company focused on developing and commercializing novel cancer diagnostic solutions, particularly for ovarian cancer. Their focus is on creating accessible and accurate diagnostic tests. The company aims to improve early detection and treatment outcomes for women's health.

Company profile →

Cleo Diagnostics (ASX:COV) has 0.00% of its shares on issue reported as short positions as of 24 Aug 2026, or about 6,300 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. COV is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads COV today

Zanger BreakoutWatchScore 20rank 1175 of 1942
CAN SLIMWatchScore 9rank 1200 of 1541
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersWatchScore 10rank 1173 of 1669

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

COV fundamentals

In the year to 30 Jun 2026, Cleo Diagnostics (ASX:COV) recorded revenue of A$1.9M and a net loss after tax of A$5.9M. A year earlier it recorded revenue of A$1.2M and a net loss after tax of A$4.0M. Year-on-year growth: revenue +64.5% (FY). Net margin −304.5%, return on equity −109.5% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →